APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyazofamid

Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.

Cyazofamid, discovered and developed by ISHIHARA SANGYO KAISHA on the global basis after first launched in 2001, is often used in downy mildew, oomycetes diseases, pepper and others.

Cyazofamid has good toxicological, environmental and ecotoxicological profiles.

In this report, we count technical grade and chapter 6 displays the preparation content.

Selected research

Market Outlook & Growth Opportunities

Global Cyazofamid Market Outlook and Growth Opportunities 2026

2 January 2026192 pages

Choose your research edition.

Industry ResearchCyazofamid Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyazofamid Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Cyazofamid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyazofamid Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyazofamid Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.

Cyazofamid, discovered and developed by ISHIHARA SANGYO KAISHA on the global basis after first launched in 2001, is often used in downy mildew, oomycetes diseases, pepper and others.

Cyazofamid has good toxicological, environmental and ecotoxicological profiles.

Read the full market overview

In this report, we count technical grade and chapter 6 displays the preparation content.

ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, with the share of 81%.

The consumption shares of Japan, China, North America and Europe were 42%, 21%, 17% and 11%. Japan is the main import region and other countries need to import from Japan.

This report provides an overview of the global Cyazofamid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cyazofamid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cyazofamid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyazofamid market size, projected growth trends, production technologies, key applications, and end-use industries.

Cyazofamid Segment by Company

ISHIHARA SANGYO KAISHA

Rudong Zhongyi

Cyazofamid Segment by Type

Agriculture Grade

Others

Cyazofamid Segment by Application

Downy Mildew

Oomycetes Diseases

Others

Cyazofamid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cyazofamid status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cyazofamid market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cyazofamid significant trends, drivers, influence factors in global and regions.

6. To analyze Cyazofamid competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyazofamid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyazofamid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyazofamid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyazofamid market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cyazofamid industry.

Chapter 3: Detailed analysis of Cyazofamid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cyazofamid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cyazofamid in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cyazofamid Industry Trends Table 2. Cyazofamid Industry Drivers Table 3. Cyazofamid Industry Opportunities and Challenges Table 4. Cyazofamid Industry Restraints Table 5. Global Cyazofamid Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cyazofamid Revenue Share by Company (2021-2026) Table 7. Global Cyazofamid Sales Volume by Company (kt) & (2021-2026) Table 8. Global Cyazofamid Sales Volume Share by Company (2021-2026) Table 9. Global Cyazofamid Average Price (USD/t) of Company (2021-2026) Table 10. Global Cyazofamid Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cyazofamid Key Company Manufacturing Base & Headquarters Table 12. Global Cyazofamid Company, Product Type & Application Table 13. Global Cyazofamid Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cyazofamid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Agriculture Grade Table 18. Significant Companies of Others Table 19. Global Cyazofamid Sales Volume by Type 2021 VS 2025 VS 2032 (kt) Table 20. Global Cyazofamid Sales Volume by Type (2021-2026) & (kt) Table 21. Global Cyazofamid Sales Volume by Type (2027-2032) & (kt) Table 22. Global Cyazofamid Sales Volume Share by Type (2021-2026) Table 23. Global Cyazofamid Sales Volume Share by Type (2027-2032) Table 24. Global Cyazofamid Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cyazofamid Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Cyazofamid Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Cyazofamid Sales Value Share by Type (2021-2026) Table 28. Global Cyazofamid Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Downy Mildew Table 30. Significant Companies of Oomycetes Diseases Table 31. Significant Companies of Others Table 32. Global Cyazofamid Sales Volume by Application 2021 VS 2025 VS 2032 (kt) Table 33. Global Cyazofamid Sales Volume by Application (2021-2026) & (kt) Table 34. Global Cyazofamid Sales Volume by Application (2027-2032) & (kt) Table 35. Global Cyazofamid Sales Volume Share by Application (2021-2026) Table 36. Global Cyazofamid Sales Volume Share by Application (2027-2032) Table 37. Global Cyazofamid Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Cyazofamid Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Cyazofamid Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Cyazofamid Sales Value Share by Application (2021-2026) Table 41. Global Cyazofamid Sales Value Share by Application (2027-2032) Table 42. Global Cyazofamid Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 43. Global Cyazofamid Sales by Region (2021-2026) & (kt) Table 44. Global Cyazofamid Sales Market Share by Region (2021-2026) Table 45. Global Cyazofamid Sales by Region (2027-2032) & (kt) Table 46. Global Cyazofamid Sales Market Share by Region (2027-2032) Table 47. Global Cyazofamid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Cyazofamid Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Cyazofamid Sales Value Share by Region (2021-2026) Table 50. Global Cyazofamid Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Cyazofamid Sales Value Share by Region (2027-2032) Table 52. Global Cyazofamid Market Average Price (USD/t) by Region (2021-2026) Table 53. Global Cyazofamid Market Average Price (USD/t) by Region (2027-2032) Table 54. Global Cyazofamid Sales by Country: 2021 VS 2025 VS 2032 (kt) Table 55. Global Cyazofamid Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Cyazofamid Sales by Country (2021-2026) & (kt) Table 57. Global Cyazofamid Sales Market Share by Country (2021-2026) Table 58. Global Cyazofamid Sales by Country (2027-2032) & (kt) Table 59. Global Cyazofamid Sales Market Share by Country (2027-2032) Table 60. Global Cyazofamid Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Cyazofamid Sales Value Market Share by Country (2021-2026) Table 62. Global Cyazofamid Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Cyazofamid Sales Value Market Share by Country (2027-2032) Table 64. ISHIHARA SANGYO KAISHA Company Information Table 65. ISHIHARA SANGYO KAISHA Business Overview Table 66. ISHIHARA SANGYO KAISHA Cyazofamid Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 67. ISHIHARA SANGYO KAISHA Cyazofamid Product Portfolio Table 68. ISHIHARA SANGYO KAISHA Recent Development Table 69. Rudong Zhongyi Company Information Table 70. Rudong Zhongyi Business Overview Table 71. Rudong Zhongyi Cyazofamid Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. Rudong Zhongyi Cyazofamid Product Portfolio Table 73. Rudong Zhongyi Recent Development Table 74. Key Raw Materials Table 75. Raw Materials Key Suppliers Table 76. Cyazofamid Distributors List Table 77. Cyazofamid Customers List Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Cyazofamid Product Image Figure 2. Global Cyazofamid Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyazofamid Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cyazofamid Sales (2021-2032) & (kt) Figure 5. Global Cyazofamid Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Cyazofamid Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Agriculture Grade Image Figure 10. Others Image Figure 11. Global Cyazofamid Sales Volume by Type (2021 VS 2025 VS 2032) & (kt) Figure 12. Global Cyazofamid Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Cyazofamid Sales Volume Share by Type (2021-2032) Figure 14. Global Cyazofamid Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cyazofamid Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cyazofamid Sales Value Share by Type (2021-2032) Figure 17. Downy Mildew Image Figure 18. Oomycetes Diseases Image Figure 19. Others Image Figure 20. Global Cyazofamid Sales Volume by Application (2021 VS 2025 VS 2032) & (kt) Figure 21. Global Cyazofamid Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Cyazofamid Sales Volume Share by Application (2021-2032) Figure 23. Global Cyazofamid Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Cyazofamid Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Cyazofamid Sales Value Share by Application (2021-2032) Figure 26. Global Cyazofamid Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 27. Global Cyazofamid Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Cyazofamid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Cyazofamid Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Cyazofamid Sales Value (2021-2032) & (US$ Million) Figure 31. North America Cyazofamid Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Cyazofamid Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Cyazofamid Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Cyazofamid Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Cyazofamid Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Cyazofamid Sales Value (2021-2032) & (US$ Million) Figure 37. South America Cyazofamid Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Cyazofamid Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Cyazofamid Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Cyazofamid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Cyazofamid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Cyazofamid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Cyazofamid Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Cyazofamid Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Agriculture Grade
  • Others
Applications
  • Downy Mildew
  • Oomycetes Diseases
  • Others
Companies covered
  • ISHIHARA SANGYO KAISHA
  • Rudong Zhongyi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyazofamid Sales Value (2021-2032)
  4. 1.2.2 Global Cyazofamid Sales Volume (2021-2032)
  5. 1.2.3 Global Cyazofamid Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cyazofamid Market Dynamics
  1. 2.1 Cyazofamid Industry Trends
  2. 2.2 Cyazofamid Industry Drivers
  3. 2.3 Cyazofamid Industry Opportunities and Challenges
  4. 2.4 Cyazofamid Industry Restraints
3 Cyazofamid Market by Company
  1. 3.1 Global Cyazofamid Company Revenue Ranking in 2025
  2. 3.2 Global Cyazofamid Revenue by Company (2021-2026)
  3. 3.3 Global Cyazofamid Sales Volume by Company (2021-2026)
  4. 3.4 Global Cyazofamid Average Price by Company (2021-2026)
  5. 3.5 Global Cyazofamid Company Ranking (2024-2026)
  6. 3.6 Global Cyazofamid Company Manufacturing Base and Headquarters
  7. 3.7 Global Cyazofamid Company Product Type and Application
  8. 3.8 Global Cyazofamid Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cyazofamid Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cyazofamid Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cyazofamid Market by Type
  1. 4.1 Cyazofamid Type Introduction
  2. 4.1.1 Agriculture Grade
  3. 4.1.2 Others
  4. 4.2 Global Cyazofamid Sales Volume by Type
  5. 4.2.1 Global Cyazofamid Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cyazofamid Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Cyazofamid Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Cyazofamid Sales Value by Type
  9. 4.3.1 Global Cyazofamid Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cyazofamid Sales Value by Type (2021-2032)
  11. 4.3.3 Global Cyazofamid Sales Value Share by Type (2021-2032)
5 Cyazofamid Market by Application
  1. 5.1 Cyazofamid Application Introduction
  2. 5.1.1 Downy Mildew
  3. 5.1.2 Oomycetes Diseases
  4. 5.1.3 Others
  5. 5.2 Global Cyazofamid Sales Volume by Application
  6. 5.2.1 Global Cyazofamid Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cyazofamid Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Cyazofamid Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Cyazofamid Sales Value by Application
  10. 5.3.1 Global Cyazofamid Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cyazofamid Sales Value by Application (2021-2032)
  12. 5.3.3 Global Cyazofamid Sales Value Share by Application (2021-2032)
6 Cyazofamid Regional Sales and Value Analysis
  1. 6.1 Global Cyazofamid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cyazofamid Sales by Region (2021-2032)
  3. 6.2.1 Global Cyazofamid Sales by Region: 2021-2026
  4. 6.2.2 Global Cyazofamid Sales by Region (2027-2032)
  5. 6.3 Global Cyazofamid Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cyazofamid Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cyazofamid Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cyazofamid Sales Value by Region (2027-2032)
  9. 6.5 Global Cyazofamid Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cyazofamid Sales Value (2021-2032)
  12. 6.6.2 North America Cyazofamid Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cyazofamid Sales Value (2021-2032)
  15. 6.7.2 Europe Cyazofamid Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cyazofamid Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cyazofamid Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cyazofamid Sales Value (2021-2032)
  21. 6.9.2 South America Cyazofamid Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cyazofamid Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cyazofamid Sales Value Share by Country, 2025 VS 2032
7 Cyazofamid Country-level Sales and Value Analysis
  1. 7.1 Global Cyazofamid Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cyazofamid Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cyazofamid Sales by Country (2021-2032)
  4. 7.3.1 Global Cyazofamid Sales by Country (2021-2026)
  5. 7.3.2 Global Cyazofamid Sales by Country (2027-2032)
  6. 7.4 Global Cyazofamid Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cyazofamid Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cyazofamid Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cyazofamid Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cyazofamid Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cyazofamid Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cyazofamid Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cyazofamid Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cyazofamid Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cyazofamid Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cyazofamid Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cyazofamid Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cyazofamid Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cyazofamid Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cyazofamid Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cyazofamid Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cyazofamid Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cyazofamid Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cyazofamid Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cyazofamid Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cyazofamid Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cyazofamid Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cyazofamid Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cyazofamid Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cyazofamid Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cyazofamid Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cyazofamid Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cyazofamid Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cyazofamid Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cyazofamid Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cyazofamid Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cyazofamid Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cyazofamid Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cyazofamid Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cyazofamid Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cyazofamid Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cyazofamid Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cyazofamid Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cyazofamid Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cyazofamid Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cyazofamid Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cyazofamid Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cyazofamid Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cyazofamid Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cyazofamid Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cyazofamid Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cyazofamid Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cyazofamid Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cyazofamid Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cyazofamid Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cyazofamid Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cyazofamid Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cyazofamid Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cyazofamid Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cyazofamid Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cyazofamid Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cyazofamid Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cyazofamid Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cyazofamid Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cyazofamid Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cyazofamid Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cyazofamid Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cyazofamid Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cyazofamid Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cyazofamid Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cyazofamid Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cyazofamid Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cyazofamid Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cyazofamid Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cyazofamid Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cyazofamid Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cyazofamid Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cyazofamid Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cyazofamid Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cyazofamid Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cyazofamid Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cyazofamid Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cyazofamid Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cyazofamid Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cyazofamid Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cyazofamid Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cyazofamid Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cyazofamid Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cyazofamid Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cyazofamid Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cyazofamid Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cyazofamid Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ISHIHARA SANGYO KAISHA
  2. 8.1.1 ISHIHARA SANGYO KAISHA Company Information
  3. 8.1.2 ISHIHARA SANGYO KAISHA Business Overview
  4. 8.1.3 ISHIHARA SANGYO KAISHA Cyazofamid Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ISHIHARA SANGYO KAISHA Cyazofamid Product Portfolio
  6. 8.1.5 ISHIHARA SANGYO KAISHA Recent Developments
  7. 8.2 Rudong Zhongyi
  8. 8.2.1 Rudong Zhongyi Company Information
  9. 8.2.2 Rudong Zhongyi Business Overview
  10. 8.2.3 Rudong Zhongyi Cyazofamid Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Rudong Zhongyi Cyazofamid Product Portfolio
  12. 8.2.5 Rudong Zhongyi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cyazofamid Value Chain Analysis
  2. 9.1.1 Cyazofamid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cyazofamid Sales Mode & Process
  6. 9.2 Cyazofamid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cyazofamid Distributors
  9. 9.2.3 Cyazofamid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst